Umeclidinium is a long-acting quaternary ammonium antimuscarinic substance. It intensely and reversibly hinders acetylcholine binding at type 3 muscarinic (M3) receptors in the bronchial smooth muscles, thus causing bronchodilation.
Vilanterol is a specific, long-acting β2-adrenergic agonist. It stimulates the release of cyclic adenosine-3′,5′- monophosphate (cAMP) by initiation of adenyl cyclase which results in the relaxation of bronchial smooth muscle.